Hany Elmariah, MD, discussed the safety profile of fedratinib and its evolving role in the post-transplant setting for patients with myeloproliferative neoplasms.

Corey Feldman was on "an isolated train to hell" before he got sober. The 53-year-old actor has been candid about his past ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

TAMPA, Fla. — The father of a Tampa man killed in a drug overdose told 10 Tampa Bay he wants justice for his son after police ...

Despite recent advancements, Sézary syndrome is associated with a high relapse rate with currently ... including those within the meaning of applicable securities laws, including the Private ...

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

Discontinuation of first-line DMTs among patients with stable MS for at least 5 years may lead to an increased risk for recurrence.

Kyle Tekiela is the host of the true-crime podcast "Crook County," which details the rise and fall of his father Ken "The Kid ...

House Bill 1398 and Senate Bill 604, also known as Victoria, Scottie, Ashleigh, and Yader’s Law in honor of four young ...

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...